Login to Your Account

Novelos, Mundipharma Sign $95M Deal for Cancer Drug

By Catherine Hollingsworth

Wednesday, February 18, 2009
Novelos Therapeutics Inc. has signed a $95 million deal with Mundipharma International Corp. Ltd. to market a cancer drug in Europe and Japan, with $10 million of that paid up front by Purdue Pharma LP, an independent company associated with the UK firm. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription